Rika Regentin
Impact in
- Pharmacology top 1%
- Microbial Natural Products and Biosynthesis
- Pharmacological Effects of Natural Compounds
- Biotechnology top 5%
Papers in
-
- Plant biochemistry and biosynthesis 8
- Microbial Metabolic Engineering and Bioproduction 3
- Enzyme Catalysis and Immobilization 1
- Heat shock proteins research 1
- Pharmacology 13
- Microbial Natural Products and Biosynthesis 12
- Pharmacological Effects of Natural Compounds 1
- Co-authors
- Hiroko Tsuruta (7 shared papers)Neil S. Renninger (3 shared papers)Tizita Horning (2 shared papers)Jay D. Keasling (2 shared papers)Christopher J. Paddon (3 shared papers)Diana G. Eng (2 shared papers)Jack D. Newman (3 shared papers)Peter Licari (11 shared papers)
- Journals
- Biotechnology Progress (4 papers)Journal of Industrial Microbiology & Biotechnology (2 papers)PLoS ONE (1 paper)Journal of Natural Products (1 paper)Biotechnology and Bioengineering (1 paper)
- Partner nations
- United StatesSouth Korea
In The Last Decade
Rika Regentin
17 papers receiving 1.3k citations
Rika Regentin's Hit Papers
Peers
Comparison fields: 5 of 62
- Pharmacology 542
- Biotechnology 171
- Molecular Biology 1.1k
- Pharmacology 96
- Toxicology 36
Countries citing papers authored by Rika Regentin
This map shows the geographic impact of Rika Regentin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rika Regentin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rika Regentin more than expected).
Fields of papers citing papers by Rika Regentin
This network shows the impact of papers produced by Rika Regentin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rika Regentin. The network helps show where Rika Regentin may publish in the future.
Co-authors
The 25 scholars most cited alongside Rika Regentin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Production of amorphadiene in yeast, and its conversion to dihydroartemisinic acid, precursor to the antimalarial agent artemisinin Hit paper breakdown → | 2012 | 608 |
| 2 | 2009 | 318 | |
| 3 | 2004 | 115 | |
| 4 | 2008 | 75 | |
| 5 | 2002 | 74 | |
| 6 | 2000 | 22 | |
| 7 | 2004 | 20 | |
| 8 | 2005 | 19 | |
| 9 | 2004 | 19 | |
| 10 | 2002 | 18 | |
| 11 | 2003 | 15 | |
| 12 | 2002 | 12 | |
| 13 | 2002 | 9 | |
| 14 | 2002 | 9 | |
| 15 | 2006 | 3 | |
| 16 | 2004 | 1 | |
| 17 | 2012 | 1 |
About Rika Regentin
Rika Regentin is a scholar working on Molecular Biology, Pharmacology, Oncology, Cell Biology and Organic Chemistry, having authored 17 papers that have together received 1.3k indexed citations. Recurring topics across this work include Microbial Natural Products and Biosynthesis (12 papers), Plant biochemistry and biosynthesis (8 papers), Cancer Treatment and Pharmacology (4 papers), Microbial Metabolic Engineering and Bioproduction (3 papers), Plant Pathogens and Fungal Diseases (2 papers), Pharmacological Effects of Natural Compounds (1 paper), Enzyme Catalysis and Immobilization (1 paper) and Heat shock proteins research (1 paper). The work is most often cited by research in Pharmacology (542 citations), Biotechnology (171 citations), Molecular Biology (1.1k citations), Pharmacology (96 citations) and Toxicology (36 citations). Rika Regentin has collaborated with scholars based in United States and South Korea. Frequent co-authors include Hiroko Tsuruta, Neil S. Renninger, Tizita Horning, Jay D. Keasling, Christopher J. Paddon, Diana G. Eng, Jack D. Newman, Peter Licari, Kirsten R. Benjamin and Michael D. Leavell. Their work appears in journals such as Biotechnology Progress, Journal of Industrial Microbiology & Biotechnology, PLoS ONE, Journal of Natural Products and Biotechnology and Bioengineering.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.